Literature DB >> 2137611

Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant.

A M Ventura1, M Q Arens, A Srinivasan, G Chinnadurai.   

Abstract

Gene expression from the human immunodeficiency virus (HIV) long terminal repeat (LTR) is strongly stimulated by the viral tat gene. The HIV LTR is also activated by several physical and chemical agents and heterologous viral genes, including adenovirus E1a. As E1a has separable transcriptional activation and repression functions, we examined the negative regulatory effects of E1a on the expression of the HIV LTR by using a trans-dominant E1a mutant. Mutant hr5 strongly suppressed the basal activity of the LTR as well as trans-activation of the LTR by heterologous agents such as the cytomegalovirus immediate early gene or DNA-damaging agents such as mitomycin C and UV irradiation. In addition, hr5 also caused significant suppression of tat gene-mediated trans-activation. The suppression of HIV LTR expression by hr5 appears to be mediated, at least in part, by the repression of the HIV enhancer, as the activity of an enhancer test system composed of the human T-cell leukemia virus I LTR containing an HIV-1 enhancer substitution was severely repressed by hr5. Cotransfection of HIV-1 proviral DNA with hr5 DNA resulted in a significant reduction of HIV production.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137611      PMCID: PMC53464          DOI: 10.1073/pnas.87.4.1310

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Identification and purification of EBP1: a HeLa cell protein that binds to a region overlapping the 'core' of the SV40 enhancer.

Authors:  L Clark; R M Pollock; R T Hay
Journal:  Genes Dev       Date:  1988-08       Impact factor: 11.361

Review 2.  Regulation of HIV and HTLV gene expression.

Authors:  H Varmus
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

3.  Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat.

Authors:  M J Selby; E S Bain; P A Luciw; B M Peterlin
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

4.  Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.

Authors:  J Sodroski; C Rosen; F Wong-Staal; S Z Salahuddin; M Popovic; S Arya; R C Gallo; W A Haseltine
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

5.  Adenovirus-2 E1A products repress enhancer-induced stimulation of transcription.

Authors:  E Borrelli; R Hen; P Chambon
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

6.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

7.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

8.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.

Authors:  R B Gaynor; M D Kuwabara; F K Wu; J A Garcia; D Harrich; M Briskin; R Wall; D S Sigman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

10.  Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.

Authors:  F K Wu; J A Garcia; D Harrich; R B Gaynor
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  11 in total

1.  Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner.

Authors:  C Suñé; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  DNA-binding properties of the E1A-associated 300-kilodalton protein.

Authors:  Y Rikitake; E Moran
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

3.  Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription.

Authors:  S F Parker; L K Felzien; N D Perkins; M J Imperiale; G J Nabel
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator.

Authors:  L K Felzien; C Woffendin; M O Hottiger; R A Subbramanian; E A Cohen; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

5.  Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth.

Authors:  H G Wang; Y Rikitake; M C Carter; P Yaciuk; S E Abraham; B Zerler; E Moran
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

6.  Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat.

Authors:  C Z Song; P M Loewenstein; M Green
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

7.  Specificity of cyclin E-Cdk2, TFIIB, and E1A interactions with a common domain of the p300 coactivator.

Authors:  L K Felzien; S Farrell; J C Betts; R Mosavin; G J Nabel
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

8.  Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells.

Authors:  B A Antoni; A B Rabson; I L Miller; J P Trempe; N Chejanovsky; B J Carter
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

Review 9.  Adenoviruses in the immunocompromised host.

Authors:  J C Hierholzer
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

10.  Adenovirus vectors block human immunodeficiency virus-1 replication in human alveolar macrophages by inhibition of the long terminal repeat.

Authors:  Robert J Kaner; Francisco Santiago; Franck Rahaghi; Elizabeth Michaels; John P Moore; Ronald G Crystal
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-05       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.